The current research consensus for GLP-1 users points to 1.2 to 1.6 grams of protein per kilogram of body weight daily
The following ranges are sourced from GoodRx price data and manufacturer list prices, accurate as of the dates noted: Ozempic: GoodRx reports average retail pricing often around $1,000-$1,200+ per month without insurance (reviewed January 8, 2026)
Semaglutide, a selective GLP-1 receptor agonist marketed as Ozempic, Wegovy, and Rybelsus, is one of the most extensively studied anti-obesity and anti-diabetes medications in history, with over 25,000 clinical trial participants and FDA approval for three distinct indications
Recent clinical trials show these medications may improve: Fatty liver disease (MASH) Cardiovascular health Metabolic disorders Inflammation Meanwhile, next-generation drugs like Retatrutide are producing nearly 29% average weight reduction in clinical studies while also improving knee osteoarthritis symptoms
This often requires a consultation with a Canadian doctor, which can be difficult to arrange if you do not live there